Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model

Hepatocellular carcinoma (HCC) is a lethal malignancy with high mortality and poor prognosis. Oncogenic transcription factor Late SV40 Factor (LSF) plays an important role in promoting HCC. A small molecule inhibitor of LSF, Factor Quinolinone Inhibitor 1 (FQI1), significantly inhibited human HCC xe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Rajasekaran, Devaraja, Siddiq, Ayesha, Willoughby, Jennifer L.S., Biagi, Jessica M., Christadore, Lisa M., Yunes, Sarah A., Gredler, Rachel, Jariwala, Nidhi, Robertson, Chadia L., Akiel, Maaged A., Shen, Xue-Ning, Subler, Mark A., Windle, Jolene J., Schaus, Scott E., Fisher, Paul B., Hansen, Ulla, Sarkar, Devanand
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694900/
https://ncbi.nlm.nih.gov/pubmed/26313006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia